Clinical trials for Stopped or missed periods

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Stopped or missed periods. For all clinical trials, go to clinical trials search

This list shows clinical trials for Stopped or missed periods

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Stopped or missed periods
Title Recruitment status Location
Watching Pregnancy Project (WPP) Investigating pregnancy-related low back pain Recruiting United Kingdom
Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A Europeah, prospective, randomised, double blind, multicenter study. - MET-AR study. Metformin in assisted reproduction. Not Recruiting United Kingdom
Pubertal Induction in Individuals With Hypogonadism Not recruiting United Kingdom
Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A European, prospective, randomised, double blind, multicenter study. - MAR-study. Metformin in assisted reporduction. Not Recruiting United Kingdom
The proposed study aims to build on the results of clinical studies DIUR-003 and DIUR-005 and evaluate the long-term safety of Chronocort® and also its long term efficacy. Authorised United Kingdom
Chronocort®, a slow release medicinal preparation of hydrocortisone, will be compared with currently used glucocorticoid replacement therapy in the treatment of congenital adrenal hyperplasia seeking to assess its safety, tolerability and effectiveness. Authorised United Kingdom
Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A European, prospective , randomised, double blind, multicenter study. - MET-AR study. Metformin in assisted reproduction. Authorised United Kingdom
Chronocort®, a slow release medicinal preparation of hydrocortisone, will be compared with currently used glucocorticoid replacement therapy in the treatment of congenital adrenal hyperplasia seeking to assess its safety, tolerability and effectiveness. Authorised United Kingdom
Chronocort®, a slow release medicinal preparation of hydrocortisone, will be compared with currently used glucocorticoid replacement therapy in the treatment of congenital adrenal hyperplasia seeking to assess its safety, tolerability and effectiveness. Authorised United Kingdom
Chronocort®, a slow release medicinal preparation of hydrocortisone, will be compared with currently used glucocorticoid replacement therapy in the treatment of congenital adrenal hyperplasia seeking to assess its safety, tolerability and effectiveness. Authorised United Kingdom

Page last reviewed: 06/10/2015

Next review due: 06/10/2017